TIVOXAVIR MARBOXIL

UNII:	8P73TA5CLC
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₅H₂₁F₂N₃O₇S₂
Preferred Substance Name:	TIVOXAVIR MARBOXIL
InChIKey:	JFAAVTYPCCKWCW-QUCCMNQESA-N
GSRS Full Record:	8P73TA5CLC i

2417851-93-3
AV-5124
AV5124
Carbonic acid, [[(12aR)-12-[(10S)-6,7-difluoro-5,10-dihydrothieno[3,2-c][2]benzothiepin-10-yl]-3,4,6,8,12,12a-hexahydro-6,8-dioxo-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl]oxy]methyl methyl ester
Tivoxavir marboxil
[(3R)-2-[(10S)-6,7-difluoro-5,10-dihydrothieno[3,2-c][2]benzothiepin-10-yl]-9,12-dioxo-5-oxa-1,2,8-triazatricyclo[8.4.0.03,8]tetradeca-10,13-dien-11-yl]oxymethyl methyl carbonate
[[(12aR)-12-[(10S)-6,7-Difluoro-5,10-dihydrothieno[3,2-c][2]benzothiepin-10-yl]-3,4,6,8,12,12a-hexahydro-6,8-dioxo-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl]oxy]methyl methyl carbonate
tivoxavir marboxil [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TIVOXAVIR MARBOXIL

Synonyms and Mappings

Resources